|
NAT10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.236600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.064430E-03 |
| Normal-vs-Stage2 |
2.680000E-02 |
| Normal-vs-Stage3 |
3.587100E-04 |
| Normal-vs-Stage4 |
5.975900E-04 |
| Stage1-vs-Stage2 |
8.677200E-01 |
| Stage1-vs-Stage3 |
2.963200E-01 |
| Stage1-vs-Stage4 |
4.391200E-01 |
| Stage2-vs-Stage3 |
4.271800E-01 |
| Stage2-vs-Stage4 |
5.358000E-01 |
| Stage3-vs-Stage4 |
8.617600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.239700E-04 |
| Normal-vs-AfricanAmerican |
1.907950E-02 |
| Normal-vs-Asian |
7.086200E-02 |
| Caucasian-vs-AfricanAmerican |
8.055600E-01 |
| Caucasian-vs-Asian |
2.992400E-01 |
| AfricanAmerican-vs-Asian |
3.769800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7657999999996E-05 |
| Normal-vs-Female |
1.600230E-03 |
| Male-vs-Female |
4.349900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.201800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.380680E-03 |
| Normal-vs-Age(61-80Yrs) |
3.820200E-04 |
| Normal-vs-Age(81-100Yrs) |
5.662500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.605000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.854200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.836420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.871200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.932800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.573400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.000600E-01 |
| Classical-VS-Follicular |
1.61128999999205E-05 |
| Classical-VS-Other |
7.983500E-02 |
| Classical-VS-Normal |
1.329840E-02 |
| Tall-VS-Follicular |
7.120300E-02 |
| Tall-VS-Other |
2.846400E-01 |
| Tall-VS-Normal |
1.278030E-02 |
| Follicular-VS-Other |
9.594600E-01 |
| Follicular-VS-Normal |
4.74060000033028E-07 |
| Other-VS-Normal |
1.275750E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.643300E-04 |
| Normal-vs-N1 |
1.974700E-04 |
| N0-vs-N1 |
5.306600E-01 |
|
|
